In Chile, at the beginning of 2011, the Dr. Luis Tisné Brousse Santiago Oriente Hospital was defined as the national reference center for HER2 ISH in breast cancer, utilizing the manual FISH technique, which was the only method validated at that time as in vitro diagnostics by the U.S. Food and Drug Administration. The gene discussed is ERBB2; the disease is breast carcinoma.